Health ❯Obesity ❯Weight Loss Treatments ❯GLP-1 Hormones
The first nonpeptide oral GLP-1 therapy, orforglipron, matches injectable drugs in weight-loss and glucose-control efficacy, with FDA filings planned for late 2025.